BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34253424)

  • 61. Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma.
    Huang H; Liu S; Xu Z; Ni S; Zhang Z; Wang X
    Medicine (Baltimore); 2017 Jul; 96(27):e7461. PubMed ID: 28682915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bilateral papillary thyroid cancer in children: Risk factors and frequency of postoperative diagnosis.
    Baumgarten H; Jenks CM; Isaza A; Bhatti T; Mostoufi-Moab S; Kazahaya K; Adzick NS; Bauer AJ
    J Pediatr Surg; 2020 Jun; 55(6):1117-1122. PubMed ID: 32171533
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence and Risk Factors for Multifocality in Pediatric Thyroid Cancer.
    Banik GL; Shindo ML; Kraimer KL; Manzione KL; Reddy A; Kazahaya K; Bauer AJ; Rastatter JC; Zafereo ME; Waguespack SG; Chelius DC; Quintanilla-Dieck L
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1100-1106. PubMed ID: 34734994
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Surgical completeness of robotic thyroidectomy: a prospective comparison with conventional open thyroidectomy in papillary thyroid carcinoma patients.
    Lee S; Lee CR; Lee SC; Park S; Kim HY; Son H; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS; Cho A
    Surg Endosc; 2014 Apr; 28(4):1068-75. PubMed ID: 24221277
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
    Garcia A; Palmer BJ; Parks NA; Liu TH
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.
    Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH
    Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
    Lee YA; Jung HW; Kim HY; Choi H; Kim HY; Hah JH; Park DJ; Chung JK; Yang SW; Shin CH; Park YJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1619-29. PubMed ID: 25632969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma.
    Ngo DQ; Ngo QX; Van Le Q
    Int J Pediatr Otorhinolaryngol; 2020 Jun; 133():110000. PubMed ID: 32200312
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy.
    Jin M; Ahn J; Lee YM; Sung TY; Kim WG; Kim TY; Ryu JS; Kim WB; Shong YK; Jeon MJ
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):602-609. PubMed ID: 32981302
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015.
    Czarniecka A; Zeman M; Wozniak G; Maciejewski A; Stobiecka E; Chmielik E; Oczko-Wojciechowska M; Krajewska J; Handkiewicz-Junak D; Jarzab B
    Front Endocrinol (Lausanne); 2021; 12():718833. PubMed ID: 34552559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
    Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
    Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?
    Han K; Noh HM; Jeong HM; Lim YC
    Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1-4 cm: implications for completion thyroidectomy following lobectomy.
    Lang BH; Shek TW; Wan KY
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):236-242. PubMed ID: 27467318
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prophylactic central neck dissection for papillary thyroid cancer.
    Barczyński M; Konturek A; Stopa M; Nowak W
    Br J Surg; 2013 Feb; 100(3):410-8. PubMed ID: 23188784
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma.
    Kim Y; Roh JL; Song DE; Cho KJ; Choi SH; Nam SY; Kim SY
    Am J Surg; 2020 Sep; 220(3):642-647. PubMed ID: 32035626
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.
    Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Roman SA; Sosa JA; Scheri RP
    J Surg Res; 2019 Nov; 243():189-197. PubMed ID: 31185435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.